AXA Launches “MediEnhancer Supplement”


Offers Up to 4% p.a. Guaranteed Returns Helping Customers To Cope With Medical Inflation

HONG KONG SAR – Media OutReach – 3 October 2022 – AXA Hong Kong and Macau (AXA) today announced the launch of “MediEnhancer Supplement” (“MediEnhancer”). “MediEnhancer” is offered exclusively to customers with qualified AXA medical insurance policies[1]. With its up to 4% p.a. guaranteed crediting interest rate, it carries a cash value which will be used to offset the annual premium of the qualified AXA medical insurance policy associated with “MediEnhancer”, relieving the pressure of medical inflation for customers.



Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause AXA’s actual results to differ materially from those expressed or implied in the forward-looking statements. Please refer to Part 4 – “Risk factors and risk management” of AXA’s Universal Registration Document for the year ended December 31, 2019, for a description of certain important factors, risks and uncertainties that may affect AXA’s business, and/or results of operations. AXA undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as part of applicable regulatory or legal obligations.